<DOC>
	<DOCNO>NCT01478893</DOCNO>
	<brief_summary>The purpose study evaluate safety pharmacodynamics SEL-068 . Increasing subcutaneous dos SEL-068 administer healthy non-smoker smoker volunteer . The result safety profile anti-nicotine antibody level evaluate .</brief_summary>
	<brief_title>Safety Pharmacodynamics SEL-068 Vaccine Smokers Non-Smokers</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Primary Healthy Smokers Healthy nonsmoker Written inform consent Primary Prior exposure nicotine vaccine Female subject childbearing potential Current use immunosuppressive agent History current autoimmune disorder immunosuppressive condition ( e.g . HIV infection ) Concurrent participation participation within 8 week prior initial study drug administration drug/device biologic investigational research study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>nicotine vaccine</keyword>
	<keyword>smoking vaccine</keyword>
	<keyword>smoke cessation</keyword>
	<keyword>SEL-068</keyword>
</DOC>